Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.

In response to numerous pathologic stimuli, the myocardium undergoes a hypertrophic response characterized by increased myocardial cell size and activation of fetal cardiac genes. We show that cardiac hypertrophy is induced by the calcium-dependent phosphatase calcineurin, which dephosphorylates the transcription factor NF-AT3, enabling it to translocate to the nucleus. NF-AT3 interacts with the cardiac zinc finger transcription factor GATA4, resulting in synergistic activation of cardiac transcription. Transgenic mice that express activated forms of calcineurin or NF-AT3 in the heart develop cardiac hypertrophy and heart failure that mimic human heart disease. Pharmacologic inhibition of calcineurin activity blocks hypertrophy in vivo and in vitro. These results define a novel hypertrophic signaling pathway and suggest pharmacologic approaches to prevent cardiac hypertrophy and heart failure.

Pubmed ID: 9568714


  • Molkentin JD
  • Lu JR
  • Antos CL
  • Markham B
  • Richardson J
  • Robbins J
  • Grant SR
  • Olson EN



Publication Data

April 17, 1998

Associated Grants

  • Agency: NHLBI NIH HHS, Id: R01 HL053351

Mesh Terms

  • Angiotensin II
  • Animals
  • Animals, Newborn
  • Atrial Natriuretic Factor
  • Calcineurin
  • Cardiomegaly
  • Cell Nucleus
  • DNA-Binding Proteins
  • GATA4 Transcription Factor
  • Immunosuppressive Agents
  • Mice
  • Mice, Transgenic
  • Myocardium
  • NFATC Transcription Factors
  • Natriuretic Peptide, Brain
  • Nuclear Proteins
  • Phenylephrine
  • Promoter Regions, Genetic
  • Rats
  • Recombinant Fusion Proteins
  • Signal Transduction
  • Transcription Factors
  • Transcription, Genetic
  • Transcriptional Activation
  • Zinc Fingers